Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
SAB Biotherapeutics (SABS)
NASDAQ:SABS
SAB Biotherapeutics (SABS) Ownership - Who Owns SAB Biotherapeutics?
56 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 08, 2023 | Eddie Joe Sullivan President,director | Bought | $1531 |
| Nov 30, 2023 | Samuel Reich Ceo & Executive Chairman,director | Bought | $9790 |
| Nov 30, 2023 | Michael King Cfo | Bought | $4500 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $16321806 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,374,081 | Institution | 25.73% | 10,944,513 | |
| 954,873 | Institution | 10.35% | 4,401,965 | |
| 273,142 | Institution | 2.96% | 1,259,185 | |
| 174,128 | Institution | 1.89% | 802,730 | |
| 84,000 | Institution | 0.91% | 387,240 | |
| 10,730 | Institution | 0.12% | 49,465 | |
| 7,256 | Institution | 0.08% | 33,450 | |
| 1,624 | Institution | 0.02% | 7,486 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 954,873 | Institution | 10.35% | 4,401,965 | |
| 273,142 | Institution | 2.96% | 1,259,185 | |
| 84,000 | Institution | 0.91% | 387,240 | |
| 10,730 | Institution | 0.12% | 49,465 | |
| 7,256 | Institution | 0.08% | 33,450 | |
| 1,624 | Institution | 0.02% | 7,486 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 131,567 | Institution | 1.43% | 597,314 | |
| 42,561 | Institution | 0.46% | 193,227 |
FAQ
Who Owns SAB Biotherapeutics (SABS)?
Currently, no data Available
What percentage of SAB Biotherapeutics (SABS) stock is held by institutional investors?
Currently, no data Available
What percentage of SAB Biotherapeutics (SABS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of SAB Biotherapeutics (SABS)?
Peter Kolchinsky owns the most shares of SAB Biotherapeutics (SABS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.